Literature DB >> 21460818

Bladder cancer: Neoadjuvant MVAC chemotherapy best for 'mixed' tumors?

Katrina Ray.   

Abstract

Entities:  

Year:  2011        PMID： 21460818     DOI： 10.1038/nrurol.2010.241

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710).

Authors:  Emil Scosyrev; Benjamin W Ely; Edward M Messing; V O Speights; H Barton Grossman; David P Wood; Ralph W de Vere White; Nicholas J Vogelzang; Donald L Trump; Ronald B Natale; Catherine M Tangen; E David Crawford; Ian M Thompson
Journal:  BJU Int       Date:  2010-11-24       Impact factor: 5.588
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.